| scholarly article | Q13442814 |
| P2093 | author name string | Naila Rabbani | |
| Paul J Thornalley | |||
| Bruce A Perkins | |||
| Leif E Lovblom | |||
| Justin A Lee | |||
| Antonysunil Adaikalakoteswari | |||
| Nancy Cardinez | |||
| Andrew Weston | |||
| P2860 | cites work | Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase | Q24290352 |
| Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease | Q26824465 | ||
| Renal catabolism of advanced glycation end products: the fate of pentosidine | Q28261351 | ||
| Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products | Q30410401 | ||
| Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy | Q30837772 | ||
| Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. | Q31112191 | ||
| Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo | Q34088186 | ||
| Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes | Q34108497 | ||
| Genetic loci influencing kidney function and chronic kidney disease | Q34109552 | ||
| Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes | Q34256592 | ||
| Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective | Q34655733 | ||
| Amino acid transport across mammalian intestinal and renal epithelia | Q34736025 | ||
| Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes | Q34762475 | ||
| Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus | Q35610369 | ||
| Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes | Q35804154 | ||
| Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre | Q36670632 | ||
| Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function | Q36714212 | ||
| Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway | Q37001887 | ||
| Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects | Q37022573 | ||
| In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. | Q37051619 | ||
| Impaired tubular uptake explains albuminuria in early diabetic nephropathy | Q37123261 | ||
| Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice | Q37403354 | ||
| Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins | Q37709995 | ||
| Need for better diabetes treatment for improved renal outcome | Q37848045 | ||
| Diabetic kidney disease with and without albuminuria | Q37855478 | ||
| The SLC3 and SLC7 families of amino acid transporters | Q38090767 | ||
| Transport of amino acids in the kidney | Q38201388 | ||
| Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation. | Q38769539 | ||
| Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments | Q38935767 | ||
| Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry | Q42048767 | ||
| alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia | Q43584213 | ||
| Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. | Q46575786 | ||
| Diabetic nephropathy: Is there a role for oxidative stress? | Q47749304 | ||
| The Relationship of Serum Soluble Receptor for Advanced Glycation End Products (sRAGE) and Carboxymethyl Lysine (CML) to the Incidence of Diabetic Nephropathy in Persons With Type 1 Diabetes | Q48255979 | ||
| A urinary proteome-based classifier for the early detection of decline in glomerular filtration. | Q49037974 | ||
| Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. | Q50301253 | ||
| Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. | Q50953396 | ||
| Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. | Q51011396 | ||
| Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus. | Q51582884 | ||
| Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. | Q52680882 | ||
| Profound mishandling of protein glycation degradation products in uremia and dialysis. | Q53624268 | ||
| The Global Epidemiology of Diabetes and Kidney Disease. | Q53698323 | ||
| A Longitudinal Study of Urinary Creatinine and Creatinine Clearance in Normal Subjects: Race, Sex, and Age Differences | Q60143254 | ||
| Advanced glycation end products in the pathogenesis of chronic kidney disease | Q60786486 | ||
| Assay of methylglyoxal-derived protein and nucleotide AGEs | Q60786514 | ||
| Negative Association between Erythrocyte Reduced Glutathione Concentration and Diabetic Complications | Q60786668 | ||
| Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications | Q60786679 | ||
| Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy | Q63170509 | ||
| Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus | Q72136248 | ||
| Serum creatinine and fat-free mass (lean body mass) | Q73038178 | ||
| Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia | Q73313415 | ||
| Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes | Q79848360 | ||
| Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems | Q83974836 | ||
| Transport of free and peptide-bound glycated amino acids: synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins | Q84022779 | ||
| Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats | Q87384397 | ||
| Unmet need in diabetic nephropathy: failed drugs or trials? | Q89398640 | ||
| Reading patterns of proteome damage by glycation, oxidation and nitration: quantitation by stable isotopic dilution analysis LC-MS/MS | Q89744199 | ||
| Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach | Q95795711 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 12709 | |
| P577 | publication date | 2020-07-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes | |
| P478 | volume | 10 |
Search more.